Boehringer Ingelheim’s Pradaxa approved in Europe
March 28, 2008Sales and Marketing
European regulators have approved Boehringer Ingelheim's novel anti-clotting pill Pradaxa, paving the way it to be launched in the coming …
Pharming’s orphan drug receives second setback in Europe
March 26, 2008Sales and Marketing HAE, Pharming
Dutch biotech company Pharming has suffered a blow, after its lead product Rhucin was rejected by European regulators for a …
NHS Trusts to promote their services to the public
March 25, 2008Medical Communications
All patients needing routine hospital care will soon be able to choose from any approved NHS trust in the country. …
Latest news from Datamonitor
March 25, 2008Sales and Marketing em
Faced with dwindling growth rates in the US and Europe, drug companies are turning their attention towards emerging pharmaceutical markets …
Early access to experimental drugs for terminally ill
March 25, 2008Sales and Marketing
Terminally ill cancer patients are to get early access to developmental drugs in a bid to halve the time it …
GSK consolidates Cervarix PR ahead of crucial vaccine decision
March 25, 2008Medical Communications
GlaxoSmithKline has reorganised the PR support for its cervical cancer vaccine Cervarix, choosing just one agency to handle the UK …
Latest news from Datamonitor
March 20, 2008Sales and Marketing
With pharmaceutical companies struggling to maintain pipelines and portfolios with products developed in-house, organizations are increasingly turning to licensing to …
Onwards and upwards
March 20, 2008Business Services career, planning, recruitment
In an era of elusive blockbusters, job cuts and growing insecurity in the pharma industry, the skills you need to …
AZ and Silence to collaborate on gene technology
March 20, 2008Research and Development
AstraZeneca has signed a deal with UK biotech firm Silence Therapeutics to develop a range of novel approaches for the …
Nexium and Seroquel face US generic fight
March 20, 2008Sales and Marketing
AstraZeneca is to face a crucial court battle over one of its biggest brands, Seroquel. Generics companies Teva and Sandoz …
Manchester selected for translational medicine centre
March 19, 2008Research and Development
A new Biomedical Research Centre of excellence is to be created in Manchester to help the UK bridge the gap …
Side-effect caution to delay Tyverb
March 19, 2008Research and Development
GlaxoSmithKline has informed regulators in the US and Europe that a small number of patients taking its new breast cancer …
Industry doubts government commitment to innovation
March 19, 2008Sales and Marketing
The government has unveiled high plans to make the UK a world leader in innovation, but the pharmaceutical industry remains …
Practice based commissioning and NICE workshops launched
March 14, 2008The impact of practice-based commissioning (PBC) on how NICE guidance is implemented will be explored in a series of regional …
Celgene buys up Pharmion
March 14, 2008Sales and Marketing
Specialist biopharma company Celgene has bought Pharmion for $2.9 billion in a bid to become a global leader in haematology …
Spend NHS surplus on out-of-hours, say primary care leaders
March 14, 2008Primary care leaders have called for some of the predicted billions in the NHS budget surplus to be spent on …
Workshops to bring together industry and NHS researchers
March 14, 2008ABPI
The pharma industry and interested NHS researchers will come together in a new initiative aimed at increasing and accelerating clinical …
Why should we listen to you?
March 12, 2008Medical Communications, Sales and Marketing industry relations, marketing, stakeholders
Last month, Pharmafocus showed how market access can be a platform to build a cohesive strategy that brings together sales, …
Latest news from Datamonitor
March 12, 2008Sales and Marketing
Type 2 diabetes driving epidemic Type 2 diabetes poses one of the greatest public health threats of the 21st century. …
Abbott to work on Tarceva diagnostic
March 12, 2008Sales and Marketing
Abbott is to develop a diagnostic test for Tarceva to identify patients who could most benefit from the lung cancer …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
